A novel multiplex imaging-based immunotherapy panel and AI-powered analysis solution identified predictive spatial biomarkers in immunotherapy- and targeted therapy-treated melanoma patients

A novel multiplex imaging-based immunotherapy panel and AI-powered analysis solution identified predictive spatial biomarkers in immunotherapy- and targeted therapy-treated melanoma patients

Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy

Selective Alanine Transporter Utilization is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer

Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor That Unleashes PD-1 Checkpoint and CAR T-Cell Immunotherapies

Immune Composition and Immunotherapy Outcomes of Mesothelioma with BAP1, CDKN2A, MTAP, and NF2 Alterations

Functional Spatial Mapping of the Tumour Immune Microenvironment In Advanced Melanoma Patients

A novel signal amplification technique for multiplex immunofluorescence to detect low-expressed biomarkers in the tumor microenvironment

A novel signal amplification technique for multiplex immunofluorescence to detect low-expressed biomarkers in the tumor microenvironment

High-dimensional spatial analysis of murine tumor microenvironment highlights the heterogeneity of primary and metastatic pancreatic cancer immune landscape

High-dimensional spatial analysis of murine tumor microenvironment highlights the heterogeneity of primary and metastatic pancreatic cancer immune landscape

Application of a Novel Multiplex Imaging-based Immunotherapy Panel and AI-powered Analysis Solution for Predictive Spatial Biomarker Identification on Immunotherapy-treated Melanoma Patients

Application of a Novel Multiplex Imaging-based Immunotherapy Panel and AI-powered Analysis Solution for Predictive Spatial Biomarker Identification on Immunotherapy-treated Melanoma Patients

The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade